The Changing Face of Cystic Fibrosis and Its Implications for Screening

Abstract

by Lutz Naehrlich
Int. J. Neonatal Screen. 2020, 6(3), 54; https://doi.org/10.3390/ijns6030054 - 15 FEB 2022
Cited by 12 | Viewed by 3503
Abstract
Early diagnosis, multidisciplinary care, and optimized and preventive treatments have changed the face of cystic fibrosis. Life expectancy has been expanded in the last decades. Formerly a pediatric disease, cystic fibrosis has reached adulthood. Mutation-specific treatments will expand treatment options and give hope for further improvement of quality of life and life expectancy. Newborn screening for CF fits perfectly into these care structures and offers the possibility of preventive treatment even before symptoms occur. Especially in countries without screening, newborn screening will fulfill that promise only with increased awareness and new care structures. Full article
(This article belongs to the Special Issue Newborn Screening for Cystic Fibrosis)
7 pages, 339 KiB
Open AccessArticle